July 01, 2019
Strongbridge Biopharma plc Added to the Russell 3000® and Microcap® Indexes
Media
June 28, 2019
Oncopeptides has completed a directed share issue of approximately SEK 727 million
June 25, 2019
MIPS ACQUIRES THE BRAND GLIDEWEAR AND THE ASSOCIATED PATENT RIGHTS
June 24, 2019
Karo Pharma acquires Trimb for MSEK 3,400
June 19, 2019
GenSight Biologics expands its Board of Directors with the appointments of Maritza McIntyre and Sofinnova Partners
June 16, 2019
New Data Presented from Oncopeptides’ Pivotal Phase 2 HORIZON Trial Evaluating Melflufen in Relapsed/Refractory Multiple Myeloma at 24th EHA Congress
June 14, 2019
New Data Presented at 24th EHA Congress from Oncopeptides’ Phase 1/2 ANCHOR Trial Evaluating Melflufen in Relapsed/Refractory Multiple Myeloma (RRMM)
June 13, 2019
Oncopeptides will host a Webcast on Monday, 17 June at 09:00 (CET) to review and update presentations from European Hematology (EHA) meeting
June 12, 2019
Strongbridge Biopharma plc to Present at the 2019 JMP Securities Life Sciences Conference
June 12, 2019
Altimmune Appoints Will Brown as Chief Financial Officer